课题基金 / 基金详情

Graduate Training in Molecular and Cellular Pharmacology

Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
批准号:
7892114
负责人:
Richard A. Anderson
金额:
$8.7万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31

项目摘要

项目成果

Richard A. Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):此续签申请请求继续支持威斯康星大学麦迪逊分校的分子和细胞药理学博士前培训(MCP)计划。几十年来,威斯康星州的药理学研究生培训一直很强大,分布在许多系和学院。1994年,威斯康星州的药理学培训学院在分子和细胞药理学项目的支持下联合起来。这创造了一个校园范围内的教职员工核心,他们在科学上高度互动,并分享对培养现代药理学家的兴趣。分子和细胞药理学项目得到了整个校园的大力支持。这一举措重振了全校的药理学课程、研讨会系列,并引发了无数跨部门的研究和培训活动,丰富了现代药理学培训的环境。这些变化对对分子和细胞药理学感兴趣的学生非常有吸引力,这导致了研究生项目招募和培训了一批杰出的年轻科学家。为了充分利用这一优越的培训环境,本提案要求继续为博士前学生提供培训资金,从10年级开始增加到12人。该计划旨在为研究生提供跨学科和综合的现代药理学基本概念培训,重点是生化、分子和细胞方法,并明确应用于人类健康。教学课程在所有这些学科中提供了坚实的基础,并建立在严格的现代药理学深入研究培训的坚实基础上。虽然培训强调的是研究职业,但培训经验的设计也是为了培养领导力和教学能力。所有的导师都有同行评议的、积极的和积极的研究计划,这些计划在分子和细胞药理学的大多数领域提供培训机会。在美国国立卫生研究院的持续支持下,MCP计划将继续加强其为美国生物医学和药物界提供训练有素的研究科学家的传统。这些科学家是药理学生物医学研究的未来。
英文摘要
DESCRIPTION (provided by applicant): This renewal application requests continuing support for the Molecular and Cellular Pharmacology Predoctoral Training (MCP) Program at the University of Wisconsin-Madison. Graduate training in pharmacology has been strong at Wisconsin for many decades and is distributed among a number of departments and colleges. In 1994, the Pharmacology training faculty at Wisconsin joined together under the auspices of the Molecular and Cellular Pharmacology Program. This has created a campus-wide nucleus of faculty who are highly interactive scientifically and share an interest in training modern pharmacologists. The Molecular and Cellular Pharmacology Program has been strongly supported across campus. This initiative ahs revitalized the campus-wide Pharmacology curriculum, seminar series, and has sparked innumerable interdepartmental research and training activities that have enriched the environment for modern Pharmacology training. These changes have been very attractive to students with an interest in molecular and cellular pharmacology, and this has resulted in the recruiting and training of an outstanding cohort of young scientists to the Graduate Program. To fully take advantage of this superior training environment, this proposal is requesting continuing funds for the training of predoctoral students, starting with an increase of to 12 starting with year 10. The Program is designed to provide graduate students with interdisciplinary and integrated training in fundamental concepts in modern pharmacology with an emphasis on biochemical, molecular and cellular approaches with clear applications to human health. The didactic curriculum provides a solid base in all of these disciplines and is built on a strong foundation of rigorous in depth research training in modern pharmacology. Although the training emphasizes a research career, the training experience is designed to develop leadership and teaching abilities as well. All of the preceptors have peer-reviewed, active, and aggressive research programs that offer training opportunities in most areas of molecular and cellular pharmacology. With continued NIH support, the MCP Program will continue to enhance its tradition of providing the U.S. biomedical and pharmacological communities with expertly trained research scientists. These scientists are the future of biomedical research in Pharmacology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tau-PI3Kalpha Complex in Regulation of PI3K/Akt-dependent Neuronal Function and Survival
  • 批准号:
    10710161
  • 项目类别:
  • 资助金额:
    $19.27万
  • 财政年份:
    2022
  • 负责人:
    Richard A. Anderson
  • 依托单位:
Phosphoinositide Signaling in the Cytosol and Nucleus
  • 批准号:
    10386086
  • 项目类别:
  • 资助金额:
    $3.82万
  • 财政年份:
    2020
  • 负责人:
    Richard A. Anderson
  • 依托单位:
Phosphoinositide Signaling in the Cytosol and Nucleus
  • 批准号:
    10323007
  • 项目类别:
  • 资助金额:
    $70.71万
  • 财政年份:
    2020
  • 负责人:
    Richard A. Anderson
  • 依托单位:
Phosphoinositide Signaling in the Cytosol and Nucleus
  • 批准号:
    10077869
  • 项目类别:
  • 资助金额:
    $70.6万
  • 财政年份:
    2020
  • 负责人:
    Richard A. Anderson
  • 依托单位:
海外基金